Mostrar el registro sencillo del ítem
COVID-19 Clinical Guidance For the Cardiovascular Care Team
dc.date.accessioned | 2020-03-29T16:29:25Z | |
dc.date.available | 2020-03-29T16:29:25Z | |
dc.date.issued | 2020-03-09 | |
dc.identifier.uri | https://www.acc.org/~/media/665AFA1E710B4B3293138D14BE8D1213.pdf | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/858 | |
dc.description.abstract | Current COVID-19 Clinical Context • The overall case fatality rate (CFR) of COVID-19 based on published reports remains low at 2.3%, with data indicating lower overall Chinese mortality outside of the outbreak epicenter in Hubei, Chinai • Beyond China, real-time reporting indicates CFRs between 2.7% (Iran) and 0.5% (South Korea); however, this information is provisional and likely to changeii • More than 80% of infected patients experience mild symptoms and recover without intensive medical interventioni • However, morbidity and mortality increase significantly with age, rising to 8.0% among patients 70-79 and 14.8% in patients over 80 in large-scale Chinese case reportingi • Published case reports from the Chinese Centers for Disease Control indicate patients with underlying comorbid conditions have a heighted risk for contracting COVID-19 and a worse prognosis; depending on the report, between 25% and 50% of COVID-19 patients present with underlying conditionsi,iii • Case fatality rates for comorbid patients are materially higher than the average population:i o Cancer: 5.6% o Hypertension: 6.0% o Chronic respiratory disease: 6.3% o Diabetes: 7.3% o Cardiovascular disease: 10.5%. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Neoplasms | en_US |
dc.subject | Cardiovascular Disease | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Chronic Respiratory Disease | en_US |
dc.subject | Risk Factors | en_US |
dc.subject | Noncommunicable Diseases | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Infectious Diseases | en_US |
dc.title | COVID-19 Clinical Guidance For the Cardiovascular Care Team | en_US |
eihealth.country | United States | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.contributor.corporatename | United States. American College of Cardiology | en_US |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |